does pfizer make glp 1 drugs Phase IIb Data Support Monthly GLP-1 Dosing for Obesity GLP-1 Drugs from the Gray

Fatty acid metabolism and thyroid hormones

Our patient Daniel (33 years old, 280 lbs, 10 years with psoriasis and PsA) saw dramatic improvements with GLP-1 therapyweight loss, reduced pain and swelling, healthier skin, and a reduced need for medications after 6 months

In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point

The probiotic strain produced high levels of succinic acid a metabolite linked to thermogenic activation

doi:10.1186/s12933-023-01897-2 Chang HY, Chou YY, Tang W, et al